News
BAYZF
58.20
-2.69%
-1.61
Bayer’s Sunharbo is now available to order in the U.S.
TipRanks · 6h ago
Bayer’s SUNHARBO® (asundexian) Now Available in the United States
Barchart · 12h ago
Jefferies Reaffirms Their Hold Rating on Bayer (0P6S)
TipRanks · 1d ago
Alpha Tau Medical: The Rubber Meets The Road In H1 2027
Seeking Alpha · 1d ago
Bayer (0P6S) Receives a Hold from Berenberg Bank
TipRanks · 2d ago
Janux Therapeutics: Potential JANX007 Comeback mCRPC And Initial JANX011 Data
Seeking Alpha · 3d ago
Weekly Report: what happened at BAYZF last week (1109-1113)?
Weekly Report · 4d ago
Bayer’s Sunharbo approved by FDA to reduce risk of stroke
TipRanks · 11/10 17:31
Bayer New Stroke Drug Can Withstand Competition -- Market Talk
Dow Jones · 11/10 14:05
Bayer (0P6S) Gets a Buy from Deutsche Bank
TipRanks · 11/10 09:55
Jefferies Reaffirms Their Hold Rating on Bayer (0P6S)
TipRanks · 11/10 08:55
Bayer gains approval of Factor XIa inhibitor asundexian to reduce stroke risk
Seeking Alpha · 11/10 02:08
ValuEngine Weekly Market Commentary With Outlook For The Remainder Of 2026
Seeking Alpha · 11/09 20:02
Weekly Report: what happened at BAYZF last week (1102-1106)?
Weekly Report · 11/09 09:00
Calley Means accuses Wiles of putting fundraising over MAHA agenda
Seeking Alpha · 11/06 20:09
BofA adds Nvidia, Microsoft, Bajaj Auto to its Global Contenders list
Seeking Alpha · 11/05 14:22
Goldman Sachs Sticks to Their Buy Rating for Bayer (0P6S)
TipRanks · 11/04 17:46
Deutsche Bank Remains a Buy on Bayer (0P6S)
TipRanks · 11/04 13:49
UBS Reaffirms Their Buy Rating on Bayer (0P6S)
TipRanks · 11/04 13:49
Bayer AG: Solid Q3 Earnings, But Still A 'Prove-It' Story
Seeking Alpha · 11/03 18:54
More
Webull provides a variety of real-time BAYZF stock news. You can receive the latest news about Bayer A G through multiple platforms. This information may help you make smarter investment decisions.
About BAYZF
Bayer AG is a German-based life science company. The Company's segments are Crop Science, Pharmaceuticals and Consumer Health. The Crop Science segment focuses on development, production and marketing of products in seeds and plant traits, crop protection, digital solutions and customer services to promote sustainable agriculture. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare and specialty therapeutics focused on the areas of cardiology, oncology, hematology and ophthalmology, as well as gene therapy and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter medicines for self-medication. Its Consumer Health segment portfolio consists of products in dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories.